We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





China Doses Thousands with Unproven COVID-19 Vaccines Having Potentially Harmful Side Effects

By HospiMedica International staff writers
Posted on 29 Sep 2020
Print article
Image: CoronaVac (Photo courtesy of Sinovac Biotech Ltd.)
Image: CoronaVac (Photo courtesy of Sinovac Biotech Ltd.)
China has administered its unproven COVID-19 vaccines to drug company workers, government officials and others before the conclusion of Phase 3 trials, worrying experts about their potential ill effects.

A report by The New York Times reveals that Chinese officials are inoculating tens of thousands, if not hundreds of thousands, of people with unproven COVID-19 vaccines outside the traditional testing process. In July, China approved three inactivated vaccines for emergency use to vaccinate high-risk groups such as medical staff. Two inactivated COVID-19 vaccines have been developed by the Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the China National Pharmaceutical Group Co., Ltd. (Sinopharm Beijing, China). The third COVID-19 vaccine named CoronaVac is from Sinovac Biotech Ltd. (Beijing, China). Another Chinese firm, CanSino Biologics Inc. (Tianjin, China), has begun conducting Phase 3 trials of its COVID-19 vaccine in Saudi Arabia, after completing the first two phases of the human trials in China.

China first began dosing workers at state-owned companies, followed by government officials and vaccine company staff. Chinese officials now plan to inoculate teachers, supermarket employees and people traveling to risky areas abroad with the unproven COVID-19 vaccines. The Chinese government could also consider expanding the scope of people qualified for emergency use and add those who work in markets, transportation and the service industry. However, global experts are worried as no other country has injected people with unproven vaccines outside the usual drug trial process on such a huge scale, states The New York Times report. The unproven vaccines could not only have harmful side effects, but also create a false sense of security and encourage behavior that could result in even more infections. Flawed vaccines can create serious health problems. Broad inoculation campaigns such as these also increase the risk of receiving multiple vaccines, which could adversely impact the immune response.

“It may be three to six months before we get Phase 3 trial results - it’s not that long to wait,” Dr. Raina MacIntyre, who heads the biosecurity program at the Kirby Institute of the University of New South Wales, told The New York Times. “You are potentially muddying the waters for the time when we do have Phase 3 trial data for the best possible vaccine.”

Related Links:
Sinovac Biotech Ltd.
China National Pharmaceutical Group Co., Ltd.
CanSino Biologics Inc.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.